CS logo
small CS logo
University of California, San Francisco Medical Center

San Francisco, California, United States
Hospital in San Francisco, California
505 Parnassus Ave, San Francisco, CA 94143
796 Beds

About University of California, San Francisco Medical Center


The University of California, San Francisco Medical Center is a research and teaching hospital in San Francisco, California and is the medical center of the University of California, San Francisco. It is affiliated with the UCSF School of Medicine.
There are 796 beds in University of California, San Francisco Medical Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of California, San Francisco
39
Children's Oncology Group
21
Novartis Pharmaceuticals
13
National Cancer Institute (NCI)
11
Pfizer
8
Bristol-Myers Squibb
7
Actelion
6
Major Extremity Trauma Research Consortium
6
Medtronic Cardiac Rhythm and Heart Failure
6
National Institute of Allergy and Infectious Diseases (NIAID)
5
Massachusetts General Hospital
4
Total Rows: 100

Clinical Trials at University of California, San Francisco Medical Center


During the past decade, University of California, San Francisco Medical Center conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 94 clinical trials were completed, i.e. on average, 68.6% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 35 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years21211616131328281717161616169911774427271212997719197722Started TrialsCompleted Trails2015201620172018201920202021202220230102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome
Completed
A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
Completed
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
Completed
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
2004-03-15
2022-12-31
Completed
53
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
2003-11-03
2021-06-30
Completed
302
"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
2003-04-01
2006-02-01
Completed
240
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
2004-09-04
2021-09-30
Completed
390
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
2004-06-01
2006-01-01
Completed
60

Rows per page:

1–100 of 279

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of California, San Francisco Medical Center" #1 sponsor was "University of California, San Francisco" with 39 trials, followed by "Children's Oncology Group" with 21 trials sponsored, "Novartis Pharmaceuticals" with 13 trials sponsored, "National Cancer Institute (NCI)" with 11 trials sponsored and "Pfizer" with 11 trials sponsored. Other sponsors include 182 different institutions and companies that sponsored additional 128 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, San Francisco Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator, "Medical University of South Carolina" with 7 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator and "University of California, San Francisco" with 5 trials as a collaborator. Other collaborators include 217 different institutions and companies that were collaborators in the rest 178 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of California,San Francisco: 39University of California,San Francisco: 39Children's Oncology Group: 21Children's Oncology Group: 21Novartis Pharmaceuticals: 13Novartis Pharmaceuticals: 13National CancerInstitute (NCI): 11National CancerInstitute (NCI): 11Pfizer: 8Pfizer: 8Bristol-Myers Squibb: 7Bristol-Myers Squibb: 7Actelion: 6Actelion: 6Major Extremity TraumaResearch Consortium: 6Major Extremity TraumaResearch Consortium: 6Medtronic CardiacRhythm and HeartFailure: 6Medtronic CardiacRhythm and HeartFailure: 6National Institute ofAllergy and InfectiousDiseases (NIAID): 5National Institute ofAllergy and InfectiousDiseases (NIAID): 5

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 23National CancerInstitute (NCI): 23National Heart, Lung,and Blood Institute(NHLBI): 9National Heart, Lung,and Blood Institute(NHLBI): 9Medical University ofSouth Carolina: 7Medical University ofSouth Carolina: 7National Institute ofNeurological Disordersand Stroke (NINDS): 6National Institute ofNeurological Disordersand Stroke (NINDS): 6University of California,San Francisco: 5University of California,San Francisco: 5National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 4National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3DePuy Spine: 3DePuy Spine: 3Immune ToleranceNetwork (ITN): 3Immune ToleranceNetwork (ITN): 3Kyowa Kirin Co., Ltd.: 3Kyowa Kirin Co., Ltd.: 3

Clinical Trials Conditions at University of California, San Francisco Medical Center


According to Clinical.Site data, the most researched conditions in "University of California, San Francisco Medical Center" are "Pulmonary Arterial Hypertension" (9 trials), "Multiple Myeloma" (7 trials), "Unspecified Childhood Solid Tumor, Protocol Specific" (7 trials), "Hepatitis B" (6 trials) and "Acute Myeloid Leukemia" (5 trials). Many other conditions were trialed in "University of California, San Francisco Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at University of California, San Francisco Medical Center


Most popular intervention types in "University of California, San Francisco Medical Center" are "Drug" (166 trials), "Biological" (49 trials), "Other" (43 trials), "Device" (34 trials) and "Procedure" (30 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (29 trials), "laboratory biomarker analysis" (18 trials), "pharmacological study" (9 trials), "cyclophosphamide" (8 trials) and "etoposide" (7 trials). Other intervention names were less common.

Clinical Trials Genders at University of California, San Francisco Medical Center


The vast majority of trials in "University of California, San Francisco Medical Center" are 271 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at University of California, San Francisco Medical Center


Currently, there are NaN active trials in "University of California, San Francisco Medical Center". undefined are not yet recruiting, 44 are recruiting, 38 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 153 completed trials in University of California, San Francisco Medical Center, 2 suspended trials, and 29 terminated clinical trials to date.
Out of the total trials that were conducted in University of California, San Francisco Medical Center, 51 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 42 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 82Phase 2: 82Phase 3: 74Phase 3: 74Phase 1: 51Phase 1: 51Not Applicable: 42Not Applicable: 42Phase 4: 8Phase 4: 8Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 153Completed: 153Recruiting: 44Recruiting: 44Active, not recruiting: 38Active, not recruiting: 38Terminated: 29Terminated: 29Enrolling by invitation: 6Enrolling by invitation: 6Withdrawn: 4Withdrawn: 4Unknown status: 3Unknown status: 3Suspended: 2Suspended: 2